Bioceres Crop Solutions Corp.

As of March 31, 2026, Bioceres Corp Solutions Corp Shs Cert Deposito Arg Repr 1 Sh carries a market capitalization of 36.51B, placing it among publicly traded companies globally. Its enterprise value stands at 386.16B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Bioceres Corp Solutions Corp Shs Cert Deposito Arg Repr 1 Sh's next confirmed earnings release is scheduled for November 17, 2026.

As of March 31, 2026, Bioceres Corp Solutions Corp Shs Cert Deposito Arg Repr 1 Sh has 56.61M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 0.10, and the price-to-book ratio stands at 0.39.

As of March 31, 2026, Bioceres Corp Solutions Corp Shs Cert Deposito Arg Repr 1 Sh trades at an EV/EBITDA multiple of 31.40 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.06 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 386.16B versus a market cap of 36.51B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Bioceres Corp Solutions Corp Shs Cert Deposito Arg Repr 1 Sh maintains a current ratio of 0.88, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 251.05, indicating elevated leverage, while an interest coverage ratio of 0.30 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Bioceres Corp Solutions Corp Shs Cert Deposito Arg Repr 1 Sh posted a negative return on equity (ROE) of -131.37, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -37.24, reflecting losses generated across the asset base. The company generates approximately 485.22M in revenue per employee across its workforce of 751.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.27 indicates how many times Bioceres Corp Solutions Corp Shs Cert Deposito Arg Repr 1 Sh sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Bioceres Corp Solutions Corp Shs Cert Deposito Arg Repr 1 Sh recorded 10.97B in income tax expense. The company reported a pretax loss of -90.86B and -341.71B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Bioceres Corp Solutions Corp Shs Cert Deposito Arg Repr 1 Sh's stock has declined approximately 86.37% over the past 52 weeks. The 50-day moving average sits at 607.05, while the 200-day moving average is 809.00.

Over the twelve months ended March 31, 2026, Bioceres Corp Solutions Corp Shs Cert Deposito Arg Repr 1 Sh generated 364.40B in revenue and converted that into -341.71B in net income, yielding earnings per share of -1,809.96. EBITDA reached 12.30B, while operating income came in at 5.35B.

As of March 31, 2026, Bioceres Corp Solutions Corp Shs Cert Deposito Arg Repr 1 Sh holds 20.59B in cash and equivalents against 331.68B in total debt, resulting in a net debt position of 296.30B. Total book value stands at 93.56B, with working capital of -50.86B providing operational flexibility.

These figures cover the twelve months ended March 31, 2026.

Over the twelve months ended March 31, 2026, Bioceres Corp Solutions Corp Shs Cert Deposito Arg Repr 1 Sh posted a gross margin of 37.17, reflecting its pricing power and cost economics. The operating margin of 1.47 and net profit margin of -93.77 provide insight into operational efficiency.

Bioceres Corp Solutions Corp Shs Cert Deposito Arg Repr 1 Sh's most recent stock split took place on January 24, 2024 with a 1:2 split ratio.